Success Stories: Our Team of Experts Acquired NIW Approval for an Applied Science Manager Researching the Field of Artificial Intelligence
Client’s Testimonial:
“First of all, many thanks to you for all your help in this life-changing journey and for getting me my NIW I-140 approved. Much appreciated really. Thank you!”
On August 20th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an Applied Science Manager in the Field of Artificial Intelligence (Approval Notice).
General Field: Artificial Intelligence
Position at the Time of Case Filing: Applied Science Manager
Country of Origin: Tunisia
State of Residence at the Time of Filing: Washington
Approval Notice Date: August 20th, 2022
Processing Time: 4 months, 16 days
Case Summary:
Considering the documentary evidence and corroborating testimony we attached to our client’s NIW (National Interest Waiver) petition established that he is a member of the professions holding an advanced degree and his research on improving the applications of AI in biomarker discovery for use in early disease detection and diagnosis, evidently has both substantial merit and national importance.
When our client, a well-established applied science manager approached North America Immigration Law Group to help him secure the NIW approval, without any ado we started evaluating his credentials and found out the best of the best information to put in his petition which led him to his NIW victory without any obstacles.
As it is required to highlight the applicant’s educational background, professional experience, and expertise, the record of publication and citation, and history of successful research in the field all indicate that the applicant is well positioned to advance the proposed endeavor. Therefore, we targeted the same pointers and added the following in our customized petition packet:
- Our client received a doctorate in computer science, proving that he is a well-qualified member of the professions holding an advanced degree.
- As an expert in the field of artificial intelligence, he intended to continue his research on the applications of artificial intelligence (AI) for biomarker discovery in order to improve the capabilities of AI for use in early disease detection and diagnosis and thereby improve the treatment of diseases such as cancer and heart disease.
- We deduced that his research is of great importance because it greatly improves the applications of AI for medical purposes, specifically for the discovery of new biomarkers related to critical diseases such as cancer, heart disease, and Alzheimer’s disease.
- He published 5 peer-reviewed conference papers (all of them first-authored) and 4 peer-reviewed journal articles (2 of them first-authored) in the top conference proceedings and journals in the field of artificial intelligence, which reflects his peers’ recognition of the value of this research.
- Not only has he successfully completed and published the results of his research in the field, but his research has also gone on to influence his peers. That is, his publications have been cited a total of 61 times, thereby demonstrating that these publications are widely recognized and relied upon in the field of artificial intelligence.
- Due to his knowledge and expertise in artificial intelligence, he has been regularly invited to conduct peer reviews for authoritative journals and conferences in the field, and he has completed at least 9 reviews to date, corroborating that he is seen as very knowledgeable in the field.